Mr. Trymore Magomana is a Global Business Development Associate for Wipro LTD. He works in their pharma, healthcare and medical devices practice in New York City, New York, United States of America. Mr. Magomana is taking a year-long deferment from a doctoral student position with Tulane University School of Public Health & Tropical Medicine, in their global health division. Mr. Magomana graduated with an MBA from The University of Illinois at Urbana-Champaign specializing in Marketing, St
It's easy to see why EpiPen has become the focus of America's fury over drug prices. It treats potentially deadly allergic reactions — for example, in a child who is stung by a bee — and its price has spiked by over 500% in a few years.
French pharmaceutical company Sanofi Pasteur says it's no longer profitable to make one of the most vital anti-venom for snakebites in Africa.Fav-Afrique counters the toxins of some of the world's most deadly venomous snakes.
India's drug export industry players such as Sun Pharmaceutical Industries, Dr. Reddy's Laboratories ($DRREDDY) and Glenmark Pharmaceuticals among others took an estimated combined hit of as much as INR5 billion ($75 million) from the sharp fall in the British pound after a U.K. referendum told the country to leave the European Union--in what has become known as "Brexit."
Advertising Age’s annual ranking of the 200 leading national advertisers in the U.S. found that pharma industry spending rose more than any other category, increasing overall by 15.6% last year.